Literature DB >> 10092701

Effective immunosuppressive therapy in a patient with primary pulmonary hypertension.

F Bellotto1, P Chiavacci, F Laveder, A Angelini, G Thiene, R Marcolongo.   

Abstract

The case history is described of a young woman who presented with primary pulmonary hypertension and non-specific inflammatory signs. The patient received prolonged immunosuppressive treatment with low dose methotrexate and prednisone without any vasodilator agent. After one year the pulmonary artery pressure fell from a mean value of 47 mm Hg to 30 mm Hg and there was a corresponding clinical response. This case suggests that, in patients with pulmonary hypertension of unknown origin, immunopathogenetic factors should be sought in order to consider the utility of immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092701      PMCID: PMC1745475          DOI: 10.1136/thx.54.4.372

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

Review 1.  Reversible or irreversible remodeling in pulmonary arterial hypertension.

Authors:  Seiichiro Sakao; Koichiro Tatsumi; Norbert F Voelkel
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-11       Impact factor: 6.914

2.  Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension.

Authors:  Wei Wang; Yu-Lin Wang; Xiao-Ying Chen; Yu-Tang Li; Wei Hao; You-Peng Jin; Bo Han
Journal:  Mol Biol Rep       Date:  2011-03-23       Impact factor: 2.316

3.  Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation.

Authors:  Ratoe Suraya; Tatsuya Nagano; Gusty Rizky Teguh Ryanto; Wiwin Is Effendi; Daisuke Hazama; Naoko Katsurada; Masatsugu Yamamoto; Motoko Tachihara; Noriaki Emoto; Yoshihiro Nishimura; Kazuyuki Kobayashi
Journal:  Respir Res       Date:  2022-06-27

4.  Impairment of monocyte-derived dendritic cells in idiopathic pulmonary arterial hypertension.

Authors:  Weiyan Wang; Hui Yan; Weiguo Zhu; Yu Cui; Junzhu Chen; Xingxiang Wang; Shan Li; Jianhua Zhu
Journal:  J Clin Immunol       Date:  2009-08-20       Impact factor: 8.317

5.  Prednisolone inhibits PDGF-induced nuclear translocation of NF-kappaB in human pulmonary artery smooth muscle cells.

Authors:  Aiko Ogawa; Amy L Firth; Weijuan Yao; Lewis J Rubin; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-15       Impact factor: 5.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.